foxo4 dri senolytic 2023 2024 foxo4-dri peptide human trial FOXO4-DRI UK Senolytic Drugs Market to Reach
Senolytic Drugs Market to Reach USD 667.6 Million by 2033 FOXO4 DRI Results: What to Expect (2026) FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $5.46 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




